Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06650878

Desarda Tissue Technique vs Lichtenstein Technique for Primary Inguinal Hernia Repair

This study aims to evaluate whether a surgical technique (Desarda) is superior to the commonly used surgical technique (Lichtenstein) in inguinal hernia repair concerning the occurrence of postoperative complications. The Lichtenstein technique involves the use of a mesh, while the Desarda technique does not.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Inguinal Hernia Unilateral Complications of Surgical Procedures or Medical Care Hernia Hernia, Abdominal Hernia, Inguinal Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with primary inguinal hernia.
  • Body mass index below 31
  • Indication for inguinal hernia repair via anterior approach, either as outpatient surgery (CMA) or elective admission.
  • Legal capacity to provide informed consent.

Exclusion criteria

  • Patients with a weak, thin, or divided external oblique aponeurosis.
  • Participants diagnosed with any of the following conditions:
  • Ongoing oncological disease
  • Cirrhotic patients classified as Child B or higher
  • Women who have previously undergone a cesarean section
  • Cognitive or affective conditions that limit the ability to cooperate with the study procedures

Treatment and study plan

Desarda

Procedure

This technique prevent from using a mesh to surgical repair of a inguinal hernia

lichtenstein

Procedure

This technique implies using a mesh to surgical repair of a inguinal hernia

Primary outcomes

  1. Rate of Participants with Post-surgery Complications

    Time frame: 3 months

    Any of the following complications: ● Sensation of a foreign body that persists beyond 3 months after surgery, self-reported by the participant ● Seroma within the first 30 days after surgery, verified through physical examination by a surgeon ● Hematoma within the first 30 days after surgery, verified through physical examination by a surgeon ● Infection at the surgical site within the first 30 days after surgery, verified by a surgeon ● Severe postoperative pain (7 or higher on the visual analog scale [VAS]) within the first 30 days after surgery, self-reported by the participant ● Chronic postoperative pain (persisting more than three months after surgery), self-reported by the participant ● Persistent loss of skin sensitivity beyond 30 days after surgery, self-reported by the participant ● Limitation of normal activities at home, outside the home, or at work beyond 3 months after surgery, self-reported by the participant

Study contacts

Contact information is provided by the study sponsor or research team.

Javier Errando, MD

CONTACT

[email protected]

+34938960025

Noemi Casaponsa

CONTACT

[email protected]

+34 938960025 ext. 43197

Sponsors and collaborators

Lead sponsor

Consorci Sanitari de l'Alt Penedès i Garraf

Other

Registry information

Official study title

Randomized Controlled Trial Comparing the Desarda Tissue Technique With the Lichtenstein Technique in Primary Inguinal Hernia Repair

Acronym: HP-tis

Important dates

Study start
2025
Primary completion
2027
Study completion
2030
First posted
Oct 21, 2024
Registry last updated
Jun 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.